Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 7/2022

30-07-2021 | Insomnia | Original Article

Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders

Authors: Jessica K. Salwen-Deremer, Michael T. Smith, Hannah G. Haskell, Colleen Schreyer, Corey A. Siegel

Published in: Digestive Diseases and Sciences | Issue 7/2022

Login to get access

Abstract

Background

Poor sleep is common in inflammatory bowel disease (IBD), predicting increased risk of flares, surgery, and/or hospitalization and reducing quality of life.

Aims

To profile specific sleep disorder symptoms in IBD, informing intervention efforts.

Methods

312 adults with Crohn’s disease or ulcerative colitis were recruited from an academic medical center in New Hampshire, USA. Participants completed online surveys about sleep including well-validated measures of sleep quality, insomnia, restless leg syndrome, sleep apnea, and circadian rhythms. Participants also answered questions about IBD-related problems that could interfere with sleep.

Results

69.4% of participants reported experiencing poor sleep and 50% reported clinically significant insomnia. Participants with active IBD symptoms were more likely to have poor sleep and insomnia. Of those with poor sleep, 67.8% met the clinical threshold for insomnia disorder and 31.3% met criteria for two or more sleep disorders. IBD-related sleep disruptions (e.g., nighttime awakenings due to bowel movements) were not significantly related to poor sleep quality, but significantly related to insomnia severity for participants with active Crohn’s disease.

Conclusions

While poor sleep in IBD is reflective of a number of different sleep problems, it is most frequently related to insomnia. IBD symptom severity contributes to insomnia, but insomnia is also distinct from IBD-related sleep disruptions. Future research on the treatment of insomnia disorder in particular in individuals with IBD is warranted.
Appendix
Available only for authorised users
Literature
1.
Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD. Sleep disturbance and risk of active disease in patients with Crohn’s disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013;11:965–971.PubMedPubMedCentral
2.
Ali T, Madhoun MF, Orr WC, Rubin DT. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflam Bowel Dis. 2013;19:2440–2443.
3.
Iskandar HN, Linan EE, Patel A, Moore R, Lasanajak Y, Gyawali CP et al. Self-reported sleep disturbance in Crohn’s disease is not confirmed by objective sleep measures. Sci Rep. 2020;10:1–9.
4.
Sofia MA, Lipowska AM, Zmeter N, Perez E, Kavitt R, Rubin DT. Poor sleep quality in Crohn’s disease is associated with disease activity and risk for hospitalization or surgery. Inflam Bowel Dis. 2020;26:1251–1259.
5.
Graff LA, Vincent N, Walker JR, Clara I, Carr R, Ediger J et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflam Bowel Dis. 2010;17:1882–1889.
6.
Keefer L, Stepanski EJ, Ranjbaran Z, Benson LM, Keshavarzian A. An initial report of sleep disturbance in inactive inflammatory bowel disease. J Clin Sleep Med. 2006;2:409–416.PubMed
7.
Uemura R, Fujiwara Y, Iwakura N, Shiba M, Watanabe K, Kamata N et al. Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare. SpringerPlus. 2016;5:1792.PubMedPubMedCentral
8.
9.
Kappelman MD, Long MD, Martin C, DeWalt DA, Kinneer PM, Chen W et al. Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12:1315–1323.PubMed
10.
Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22:1748–1753.PubMed
11.
Scott AJ, Flowers O, Rowse G. A comparative study of the nature and magnitude of problems sleeping in inflammatory bowel disease (IBD) compared to healthy controls. Psychol Health Med. 2020;20:1–11.
12.
Chrobak AA, Nowakowski J, Zwolińska-Wcisło M, Cibor D, Przybylska-Feluś M, Ochyra K et al. Associations between chronotype, sleep disturbances and seasonality with fatigue and inflammatory bowel disease symptoms. Chronobiol Int. 2018;35:1142–1152.PubMed
13.
Becker J, Berger F, Schindlbeck KA, Poddubnyy D, Koch PM, Preiß JC et al. Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease. Int J Colorectal Dis. 2018;33:955–962.PubMed
14.
Cohen ER, Melmed GY. Making a case for patient-reported outcomes in clinical inflammatory bowel disease practice. Clin Gastroenterol Hepatol. 2018;16:603–607.PubMed
15.
Bewtra M, Brensinger CM, Tomov VT, Hoang TB, Sokach CE, Siegel CA et al. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index. Inflam Bowel Dis. 2014;20:1070–1078.
16.
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psych Res. 1989;28:193–213.
17.
Heslop P, Smith GD, Metcalfe C, Macleod J, Hart C. Sleep duration and mortality: the effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med. 2002;3:305–314.PubMed
18.
19.
20.
Allen RP, Burchell BJ, MacDonald B, Hening WA, Earley CJ. Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey. Sleep Med. 2009;10:1097–1100.PubMed
21.
Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW et al. Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15:860–873.PubMed
22.
23.
Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34:601–608.PubMedPubMedCentral
24.
Horne JA, Östberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;25:958–968.
25.
Kantermann T, Sung H, Burgess HJ. Comparing the morningness-eveningness questionnaire and munich chronotype questionnaire to the dim light melatonin onset. J Biol Rhyt. 2015;30:449–453.
26.
Chakradeo PS, Keshavarzian A, Singh S, Dera AE, Esteban JPG, Lee AA et al. Chronotype, social jet lag, sleep debt and food timing in inflammatory bowel disease. Sleep Med. 2018;52:188–195.PubMedPubMedCentral
27.
Taillard J, Philip P, Chastang J-F, Bioulac B. Validation of Horne and Ostberg morningness-eveningness questionnaire in a middle-aged population of French workers. J Biol Rhyt. 2004;19:76–86.
28.
Paine S-J, Gander PH, Travier N. The epidemiology of morningness/eveningness: influence of age, gender, ethnicity, and socioeconomic factors in adults (30–49 years). J Biol Rhyt. 2006;21:68–76.
29.
Ong JC, Huang JS, Kuo TF, Manber R. Characteristics of insomniacs with self-reported morning and evening chronotypes. J Clin Sleep Med. 2007;3:289–294.PubMedPubMedCentral
30.
Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S et al. Stop questionnairea tool to screen patients for obstructive sleep apnea. Anesthesiol J Am Soc Anesthesiol. 2008;108:812–821.
31.
Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65–70.
32.
Kim H-Y. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38:52.PubMedPubMedCentral
33.
Sochal M, Małecka-Panas E, Gabryelska A, Talar-Wojnarowska R, Szmyd B, Krzywdzińska M et al. Determinants of sleep quality in inflammatory bowel diseases. J Clin Med. 2020;9:2921.PubMedCentral
34.
Singareddy R, Vgontzas AN, Fernandez-Mendoza J, Liao D, Calhoun S, Shaffer ML et al. Risk factors for incident chronic insomnia: a general population prospective study. Sleep Med. 2012;13:346–353.PubMedPubMedCentral
35.
Mai E, Buysse DJ. Insomnia: prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Sleep Med Clin. 2008;3:167–174.PubMedPubMedCentral
36.
Scott AJ, Flowers O, Rowse G. Do specific types of sleep disturbances represent risk factors for poorer health‐related quality of life in inflammatory bowel disease? A longitudinal cohort study. Br J Health Psychol. 2020:e12457.
37.
38.
Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30:213–218.PubMed
39.
Burish MJ, Chen Z, Yoo SH. Emerging relevance of circadian rhythms in headaches and neuropathic pain. Acta Physiol. 2019;225:e13161.
40.
Hagenauer MH, Crodelle JA, Piltz SH, Toporikova N, Ferguson P, Booth V. The modulation of pain by circadian and sleep-dependent processes: a review of the experimental evidence. Women Math Biol. 2017; 1–21.
41.
42.
Koo BB. Restless leg syndrome across the globe: epidemiology of the restless legs syndrome/Willis-Ekbom disease. Sleep Med Clin. 2015;10:189–205.PubMed
43.
Mosli MH, Bukhari LM, Khoja AA, Ashour NA, Aljahdali HR, Khoja OA et al. Inflammatory bowel disease and restless leg syndrome. Neurosci (Riyadh, S Arab). 2020;25:301–307.
44.
Strange C, Richard CL, Shan S, Phillips BA, Kanotra S, Drummond MB et al. A population-based estimate of the health care burden of obstructive sleep apnea using a STOP-BAG questionnaire in South Carolina. J Clin Sleep Med. 2020
45.
Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep. 2010;33:1159–1164.PubMedPubMedCentral
46.
Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17:241–254.PubMedPubMedCentral
47.
Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165:125–133.PubMed
48.
Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med. 2004;164:1888–1896.PubMed
49.
Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psych. 2002;159:5–11.
50.
Morin CM. Cognitive behavioral therapy for chronic insomnia: state of the science versus current clinical practices. Ann Intern Med. 2015;163:236–237.PubMed
51.
Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012;35:769–781.PubMedPubMedCentral
52.
Ritterband LM, Thorndike FP, Ingersoll KS, Lord HR, Gonder-Frederick L, Frederick C et al. Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trial. JAMA Psych. 2017;74:68–75.
53.
Salwen-Deremer JK, Siegel CA, Smith MT. Cognitive behavioral therapy for Insomnia: a promising treatment for insomnia, pain, and depression in patients with IBD. Crohn’s Colitis 360. 2020;2:otaa052.
54.
Taylor DJ, Pruiksma KE. Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: a systematic review. Int Rev Psych. 2014;26:205–213.
55.
Zeng L-N, Zong Q-Q, Yang Y, Zhang L, Xiang Y-F, Ng CH et al. Gender difference in the prevalence of Insomnia: a meta-analysis of observational studies. Front Psych. 2020;11.
56.
Johnson DA, Jackson CL, Williams NJ, Alcántara C. Are sleep patterns influenced by race/ethnicity–a marker of relative advantage or disadvantage? Evidence to date. Nat Sci Sleep. 2019;11:79.PubMed
57.
Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:1246–1256.PubMed
58.
Zeitz J, Ak M, Müller-Mottet S, Scharl S, Biedermann L, Fournier N et al. Pain in IBD patients: very frequent and frequently insufficiently taken into account. PLoS ONE. 2016;11:e0156666.PubMedPubMedCentral
59.
Edwards RR, Almeida DM, Klick B, Haythornthwaite JA, Smith MT. Duration of sleep contributes to next-day pain report in the general population. PAIN. 2008;137:202–207.PubMedPubMedCentral
60.
Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. J Pain. 2013;14:1539–1552.PubMedPubMedCentral
61.
Afolalu EF, Ramlee F, Tang NK. Effects of sleep changes on pain-related health outcomes in the general population: a systematic review of longitudinal studies with exploratory meta-analysis. Sleep Med Rev. 2018;39:82–97.PubMedPubMedCentral
62.
Taylor DJ, Wilkerson AK, Pruiksma KE, Williams JM, Ruggero CJ, Hale W et al. Reliability of the structured clinical interview for DSM-5 sleep disorders module. J Clin Sleep Med. 2018;14:459–464.PubMedPubMedCentral
Metadata
Title
Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders
Authors
Jessica K. Salwen-Deremer
Michael T. Smith
Hannah G. Haskell
Colleen Schreyer
Corey A. Siegel
Publication date
30-07-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07176-y

Other articles of this Issue 7/2022

Digestive Diseases and Sciences 7/2022 Go to the issue

Editorial

Ballooning Your Way in Altered Anatomy ERCP: Ready for Deductive Learning

Original Article

Gender Differences in Liver Transplantation Outcomes in Polycystic Liver Disease

Correspondence

A Commentary on Intracystic Glucose Levels Appear Useful for Diagnosis of Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis

Original Article

CircTUBGCP3 Contributes to the Malignant Progression of Rectal Cancer

Original Article

A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease

Original Article

Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits